Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle

气道平滑肌区室化钙信号传导的功能多样性

基本信息

  • 批准号:
    9901263
  • 负责人:
  • 金额:
    $ 3.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-15 至 2021-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary In the proposed studies we seek to disentangle the complex effects of intracellular calcium in the regulation of airway smooth muscle (ASM) contraction. Although biochemical events mediating the effects of calcium on cross-bridge cycling and contraction have been understood and accepted for years, what remains mystifying is how the ASM cell compartmentalizes calcium to regulate the contractile machinery. Our recent findings demonstrate that conventional and simplistic assessments of intracellular calcium signaling have no predictive ability regarding regulation of smooth muscle contractile state. In recent publications we demonstrate the seemingly paradoxical ability of elevated intracellular calcium to mediate relaxation of ASM when stimulated by agonists of bitter taste receptors (TAS2Rs) whereas almost all other G protein-coupled receptors (GPCRs) capable of inducing increased intracellular calcium mediate contraction. Similarly, ligands such as natural flavonoids, chloride channel antagonists, GABAA agonists cause acute ASM relaxation despite causing an acute transient [Ca2+]i increase. Clearly, the disparate effects by GPCRs on ASM contractile state reflect the long-appreciated but poorly-understood ability of the cell to compartmentalize calcium signaling. The relaxant effect of calcium signaling, if understood, could be exploited therapeutically for the management of the airway hyperresponsiveness. To achieve our goal we will combine expertise and strategies in 5 major areas: GPCR biology, biophysics of calcium, cell imaging, proteomics and mathematical modeling. Aim 1 studies will define the mechanisms involved in spatial and temporal distribution of calcium signaling in ASM induced by different GPCR agonists. We will define and localize all proteins, structural elements, and enzymatic activities that regulate calcium distribution in ASM cells stimulated with different GPCR agonists. We will test how disruption of these regulatory elements alters the features of intracellular calcium and the associated regulation of ASM tone. In aim 2 studies, we will employ hyperspectral imaging and phosphoproteomics tools to discern GPCR- specific activation of effector proteins in ASM. With these data we will develop descriptive and predictive mathematical models (Aim 3) that define the key regulatory features enabling compartmentalized calcium signaling and predict the functional consequences of such signaling. The computational models will be validated using experimental data obtained through studies using primary human airway smooth muscle cells and tissues. Our success banks on the unique ability of our team to creatively apply and coordinate cutting edge imaging approaches, multi-fluorophore hyperspectral image analysis, and modeling to well-defined experimental systems that demonstrate disparate and unexplained functional consequences of intracellular calcium. The findings will not only advance the basic science fields of receptor biology and calcium signaling, but also identify targets whose manipulation could be exploited for developing novel bronchodilator therapies.
项目摘要 在所提出的研究中,我们试图解开细胞内钙离子在调节中的复杂作用, 气道平滑肌(ASM)收缩。虽然生化事件介导的影响,钙对 过桥自行车和收缩已经被理解和接受多年,仍然令人困惑的是, ASM细胞如何分隔钙来调节收缩机制。我们最近的发现 表明细胞内钙信号传导的传统和简单的评估没有预测性, 调节平滑肌收缩状态的能力。在最近的出版物中,我们展示了 当受到刺激时,细胞内钙离子升高介导ASM松弛的能力似乎是矛盾的。 苦味受体激动剂(TAS 2 R),而几乎所有其他G蛋白偶联受体(GPCR) 能够诱导增加的细胞内钙介导的收缩。类似地,配体如天然的 类黄酮、氯离子通道拮抗剂、GABAA激动剂引起急性ASM松弛,尽管它们引起急性平滑肌松弛。 急性一过性[Ca 2 +]i升高。显然,GPCR对ASM收缩状态的不同影响反映了 细胞对钙信号进行区室化的能力长期受到重视,但了解甚少。舒张 钙信号传导的作用,如果被理解,可以在治疗上用于气道的管理 高反应性为了实现我们的目标,我们将联合收割机的专业知识和战略结合在5个主要领域: 生物学、钙生物物理学、细胞成像、蛋白质组学和数学建模。目标1研究将定义 不同浓度的钙离子对平滑肌细胞钙信号时空分布的影响 GPCR激动剂。我们将定义和定位所有的蛋白质,结构元件,和酶的活动, 调节用不同GPCR激动剂刺激的ASM细胞中的钙分布。我们将测试 这些调节元件的改变细胞内钙的特征和ASM的相关调节 语气在目标2研究中,我们将采用高光谱成像和磷酸蛋白质组学工具来辨别GPCR- 特异性激活ASM中的效应蛋白。有了这些数据,我们将开发描述性和预测性的 数学模型(目标3),定义了关键的调控功能,使区室化钙 信号并预测这种信号的功能后果。计算模型将是 使用通过使用原代人气道平滑肌细胞的研究获得的实验数据进行验证 和纸巾。我们的成功依赖于我们团队创造性地应用和协调切割的独特能力 边缘成像方法、多荧光团高光谱图像分析以及明确定义的建模 这些实验系统证明了细胞内免疫的不同和无法解释的功能后果, 钙这些发现不仅将推进受体生物学和钙信号传导的基础科学领域, 而且还鉴定其操作可用于开发新型支气管扩张剂疗法的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deepak A Deshpande其他文献

Deepak A Deshpande的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deepak A Deshpande', 18)}}的其他基金

Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma.
优化功能选择性 ERK1/2 抑制剂以减少 AP-1 介导的哮喘气道病理。
  • 批准号:
    10666887
  • 财政年份:
    2023
  • 资助金额:
    $ 3.34万
  • 项目类别:
tRNA-derived non-coding RNAs in ASM function and in asthma
tRNA 衍生的非编码 RNA 在 ASM 功能和哮喘中的作用
  • 批准号:
    10434062
  • 财政年份:
    2020
  • 资助金额:
    $ 3.34万
  • 项目类别:
tRNA-derived non-coding RNAs in ASM function and in asthma
tRNA 衍生的非编码 RNA 在 ASM 功能和哮喘中的作用
  • 批准号:
    10643968
  • 财政年份:
    2020
  • 资助金额:
    $ 3.34万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10204427
  • 财政年份:
    2019
  • 资助金额:
    $ 3.34万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10588000
  • 财政年份:
    2019
  • 资助金额:
    $ 3.34万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10090626
  • 财政年份:
    2019
  • 资助金额:
    $ 3.34万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    10349442
  • 财政年份:
    2019
  • 资助金额:
    $ 3.34万
  • 项目类别:
Diacylglycerol kinase in airway smooth muscle functions
二酰甘油激酶在气道平滑肌功能中的作用
  • 批准号:
    9898459
  • 财政年份:
    2019
  • 资助金额:
    $ 3.34万
  • 项目类别:
Functional Diversity of Compartmentalized Calcium Signaling in Airway Smooth Muscle
气道平滑肌区室化钙信号传导的功能多样性
  • 批准号:
    10062409
  • 财政年份:
    2017
  • 资助金额:
    $ 3.34万
  • 项目类别:
Evaluation of novel substrate specific inhibitors of ERK1/2 in the treatment of asthma
新型ERK1/2底物特异性抑制剂治疗哮喘的评价
  • 批准号:
    9293245
  • 财政年份:
    2016
  • 资助金额:
    $ 3.34万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 3.34万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了